4//SEC Filing
Harrison Kenneth Ph.D. 4
Accession 0001209191-21-026339
CIK 0001637715other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 3:16 PM ET
Size
5.2 KB
Accession
0001209191-21-026339
Insider Transaction Report
Form 4
Harrison Kenneth Ph.D.
Director
Transactions
- Award
Stock Option (right to buy)
2021-04-08+14,000→ 14,000 totalExercise: $15.00Exp: 2031-04-07→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest on April 8, 2022.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001852977
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 3:16 PM ET
- Size
- 5.2 KB